More on QGEN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $42.13 |
|
|||
| Open | $42.58 | ||||
| 52 Wk High | $28.50 | ||||
| 52 Wk Low | $19.94 | ||||
| Day High | $42.65 | ||||
| Day Low | $42.02 | ||||
| P/E | 146.55 | ||||
| EPS | $0.29 | ||||
| Volume | 1,107,756 | ||||
- UBS Assumes Qiagen NV (QGEN) at Neutral
- Form 6-K QIAGEN N.V. For: Sep 30
- Jury finds Parse Biosciences willfully infringed 10x Genomics patents
- 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
- QIAGEN launches QIAsymphony Connect nucleic acid extraction platform
- QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
- Qiagen names Jonathan Pratt as CEO amid takeover talks
- Qiagen names Jonathan Pratt as CEO, replacing Thierry Bernard
- QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
- Qiagen (QGEN) Halted, News Pending
Entities mentioned with QGEN
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Stock Buyback | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
